Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012)
Clinical trial NCT01848834 · COMPLETED
Trial details
- NCT number
- NCT01848834
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-07
- Primary completion
- 2016-04-26
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.